Wendy Selig is the founder and CEO of WSCollaborative, a firm that focuses on defining and implementing strategies for establishing winning cross-sector collaborations in the healthcare arena. She is known for her collaborative approach to engagement, with a record of “connecting the dots” and fostering novel partnerships.
From 2009 to 2015, she served as President and CEO of the Melanoma Research Alliance (MRA), where she led and managed MRA’s strategic priorities, research portfolio, engagement with more than 90 corporate and nonprofit allies, and day-to-day operations. MRA, founded by Debra and Leon Black under the auspices of the Milken Institute, is the largest private funder of melanoma research.
Throughout her career, she has held leadership roles in numerous coalitions, including serving as founding President of United for Medical Research (UMR) and chair of One Voice Against Cancer (OVAC). She has served on the National Cancer Institute (NCI) Director’s Consumer Liaison Group (DCLG) and is currently President of the National Coalition of Cancer Research (NCCR). She has served on the Patient Leadership Council of the Clinical Trials Transformation Initiative (CTTI) and the Government Affairs Committee of the Prostate Cancer Foundation (PCF), as well as the National Comprehensive Cancer Network’s (NCCN) Tissue Allocation Subcommittee.
Prior to joining the MRA, she spent nearly a decade in leadership positions at the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Most recently, she served as ACS CAN's Vice President of External Affairs and Strategic Alliances, where she built strategic partnerships among corporations, foundations, trade associations, and federal agencies. Her work with the American Cancer Society and ACS CAN began in 2000, when she served first as Managing Director, Federal Government Relations, and later Vice President for Legislative Affairs. From 1989 to 2000, she served on Capitol Hill as a senior staff member.